The national drug price regulator National Pharmaceutical Pricing Authority (NPPA) has revised and fixed prices of 85 formulation packs and 10 bulk drugs, including non ceiling prices of various brands of multinational companies.

The maximum retail price and the non ceiling prices were fixed for various strengths and packs of Actrapid Flex Pen, Insulatard Flex Pen and Mixtard 30 Flex Pen marketed by Novo Nordisk India Pvt Ltd, various combinations of insulin products - Biosulin and Lupisulin - marketed M J Biopharm Pvt Ltd and Theophylline Syrup manufactured by Cipla Ltd through these notifications.

Prices of different packs and strengths of Pfizer India's cortecosteroid Solu Medrol, Depo Medrol and Medrol, Shreya Life sciences' buccal insulin Recosulin have been revised with a marginal increase. Prices of various packs of Vitalux Plus tablet imported by Novartis India Ltd, a range of insulin solutions – Insuman - imported by sanofi aventis Pharma Ltd, Human Actrapid, Human Mixtard and Human Insulatard manufactured by Torrent Pharmaceutical Ltd along with the price of Wockhardt's pain killer drug Spasmo Proxyvon have also been increased by the national drug price regulator.

The ceiling price of various strengths and packs of chlorpromazine with combinations, sulfsalazine, ascorbic acid with combinations, prednisolone, naproxen sodium, dextropropoxyphene HCl capsule and tablet forms with combinations, levosalbutamol with combinations, erythromycin estolate, gentamycin with combinations, dexamethasone sodium and Ofloxacin with combinations has also been revised through notification.

Further, through another notification, the authority has revised prices for a range of bulk drugs including Vitamin A Palmitate and Vitamin A Acetate with quantity 1000 MIU and norfloxacin, pentoxyphylline, Vitamin C and sodium ascorbate, famotidine and phenyl butazone per kilo gram.

The ceiling and non ceiling prices for the formulation packs were fixed through two notifications, one in the beginning of December 2009 and the latest on January 21, 2010. The prices for bulk drugs were notified on January 20, 2010.

The fixed and revised notified prices will be effective within 15 days from the date of notification in the Official Gazette and all formulators utilizing these drugs in their scheduled formulations are advised to follow the provisions of DPCO, 1995, orders the NPPA notification.